Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity

Blood

Volumn 97, Issue 4, 2001, Pages 922-928

  Gillessen, S ^a   Mach, N ^a   Small, C ^a   Mihm, M ^a   Dranoff, G ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CONTACT ALLERGY; CONTROLLED STUDY; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMOSTASIS; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035865595     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.4.922     Document Type: Article

References (55)

1. Hemopoietic regulators: Redundancy or subtlety?
2. Chromosomal localization and organization of the murine genes encoding the β subunits (A/C2A and A/C2B) of the interleukin 3, granulocyte/macrophage colony-stimulating factor and interleukin 5 receptors
3. Fine-structure mapping of the murine IL-3 and GM-CSF genes by pulsed-field gel electrophoresis and molecular cloning
4. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
5. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
6. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation
7. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice
8. The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 βc receptor-deficient mice is reversed by bone marrow transplantation
9. Mice deficient for the IL-3/GM-CSF/IL-5 βc receptor exhibit lung pathology and impaired immune response, while βIL-3 receptor-deficient mice are normal
10. Hematopoietic and lung abnormalities in mice with a null mutation of the common β subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5
11. Distinct changes in pulmonary surfactant homeostasis in common β-chain- and GM-CSF-deficient mice
12. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5Rα-deficient mice
13. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
14. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor
15. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common β chain expression
16. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice
17. Regulation of IFN-γ production in granulocyte-macrophage colony-stimulating factor-deficient mice
18. Functional analysis of mature hematopoietic cells from mice lacking the βc chain of the granulocyte-macrophage colony-stimulating factor receptor
19. Functional deficiencies of peritoneal cells from gone-targeted mice lacking G-CSF or GM-CSF
20. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice
21. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection
22. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice
23. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice
24. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice
25. Involvement of interleukin-3 in delayed-type hypersensitivity
26. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites
27. Functional inactivation in mice of the gene for the interleukin-3 (IL-3)-specific receptor β-chain: Implications for IL-3 function and the mechanism of receptor transmodulation in hematopoietic cells
28. Cytokines: Coordinators of immune and inflammatory responses
29. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival
30. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease
31. Cytokine production and function in c-mpl-deficient mice: No physiologic role for interleukin-3 in residual megakaryocyte and platelet production
32. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions
33. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences
34. Transgenic mice for the preparation of hygromycin-resistant primary embryonic fibroblast feeder layers for embryonic stem cell selections
35. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or flt3-ligand
36. Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions
37. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and longlasting anti-tumor immunity
38. + cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system
39. Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice
40. Activities of granulocyte-macrophage colony stimulating factor revealed by gene transfer and gene knockout studies
41. Origin, maturation, and antigen presenting function of dendritic cells
42. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs
43. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
44. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice
45. Elicitation of delayed allergic skin reactions with haptens: The dependence of elicitation on hapten combination with protein
46. The role of Langerhans cells in allergic contact hypersensitivity: A review of findings in man and guinea pigs
47. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity
48. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion
49. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
50. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
51. Distinct roles for B7 costimulation in contact hypersensitivity and humoral immune responses to epicutaneous antigen
52. Suppression of murine allergic contact dermatitis by CTLA4lg: Tolerance induction of Th2 responses requires additional blockade of CD40-ligand
53. Vaccination with irradiated, autologous melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor generates potent anti-tumor immunity in patients with metastatic melanoma
54. Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex
55. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice